We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI System Quantifies Lung Lesions and Airway Volumes on CT Imaging in IPF Patients

By MedImaging International staff writers
Posted on 11 Apr 2022
Print article
Image: Novel AI-based technology for chest CT analysis of idiopathic pulmonary fibrosis (Photo courtesy of Unsplash)
Image: Novel AI-based technology for chest CT analysis of idiopathic pulmonary fibrosis (Photo courtesy of Unsplash)

There is a growing need to accurately estimate the prognosis of idiopathic pulmonary fibrosis (IPF) in clinical practice, given the development of effective drugs for treating IPF. Scientists have developed an artificial intelligence (AI)-based image analysis software to detect parenchymal and airway abnormalities on computed tomography (CT) imaging of the chest and to explore their prognostic importance in patients with IPF.

Scientists from the Kyoto University (Kyoto, Japan) developed the novel AI-based quantitative CT image analysis software (AIQCT) by applying 304 high-resolution CT (HRCT) scans from patients with diffuse lung diseases as the training set. AIQCT automatically categorized and quantified 10 types of parenchymal patterns as well as airways, expressing the volumes as percentages of the total lung volume. To validate the software, the area percentages of each lesion quantified by AIQCT were compared with those of the visual scores using 30 plain high-resolution CT images with lung diseases. In addition, three-dimensional analysis for similarity with ground truth was performed using HRCT images from 10 patients with IPF. AIQCT was then applied to 120 patients with IPF who underwent HRCT scanning of the chest at our institute. The associations between the measured volumes and survival were analyzed.

The scientists found that the correlations between AIQCT and the visual scores were moderate to strong (correlation coefficient 0.44–0.95) depending on the parenchymal pattern. The Dice indices for similarity between AIQCT data and ground truth were 0.67, 0.76, and 0.64 for reticulation, honeycombing, and bronchi, respectively. During a median follow-up period of 2,184 days, 66 patients died, and one underwent lung transplantation. In multivariable Cox regression analysis, bronchial volumes (adjusted hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.16–1.53) and normal lung volumes (adjusted HR, 0.97; 95% CI, 0.94–0.99) were independently associated with survival after adjusting for the gender-age-lung physiology stage of IPF.

Based on their findings, the scientists concluded that their newly-developed AI-based image analysis software successfully quantified parenchymal lesions and airway volumes. According to the scientists, bronchial and normal lung volumes on HRCT imaging of the chest can provide additional prognostic information on the gender-age-lung physiology stage of IPF.

Related Links:
Kyoto University 

New
Ultrasound Table
Women’s Ultrasound EA Table
New
Ultrasonic Pocket Doppler
SD1
Portable Color Doppler Ultrasound System
S5000
New
Stereotactic QA Phantom
StereoPHAN

Print article

Channels

Ultrasound

view channel
Image: The model trained on echocardiography, can identify liver disease in people without symptoms (Photo courtesy of 123RF)

Artificial Intelligence Detects Undiagnosed Liver Disease from Echocardiograms

Echocardiography is a diagnostic procedure that uses ultrasound to visualize the heart and its associated structures. This imaging test is commonly used as an early screening method when doctors suspect... Read more

Nuclear Medicine

view channel
Image: A repurposed ALS drug has become an imaging probe to help diagnose neurodegeneration (Photo courtesy of St. Jude Children’s Research Hospital)

Innovative PET Imaging Technique to Help Diagnose Neurodegeneration

Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease, are often diagnosed only after physical symptoms appear, by which time treatment may no longer be effective.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.